FDA Tells Doctors in 8 States to Stop Using COVID-19 Treatment

If the FDA and the CDC oppose it then it must work. This is the new science.

FDA Tells Doctors in 8 States to Stop Using COVID-19 Treatment

By;: Zachary Stieber, The Epoch Times, March 27, 2022:

U.S. drug regulators have directed health care workers in eight states to stop using a COVID-19 treatment because it may not be effective against an Omicron coronavirus subvariant that’s rising in prevalence.

Story continues below advertisement

The Food and Drug Administration (FDA) said sotrovimab, a monoclonal antibody used to treat COVID-19, can no longer be used in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, and Vermont.

Providers in Puerto Rico and the Virgin Islands also have been told to stop using stotrovimab.

Regulators believe that the treatment, which was given emergency use authorization in May 2021, “is unlikely to be effective against the BA.2 subvariant,” the FDA said in a statement.

BA.2 is a subvariant of Omicron, a variant of the CCP (Chinese Communist Party) virus, the pathogen that causes COVID-19.

According to genomic surveillance conducted by the Centers for Disease Control and Prevention, BA.2 was responsible for 12.6 percent of COVID-19 cases in the United States in the week ending on March 5. But the agency projected an increase to 35 percent in the week ending on March 19, and the subvariant was pegged as circulating widely in the northeast.

Based on the estimates, BA.2 is responsible for the majority of the cases in the states where the administration of sotrovimab is now limited.

The FDA had indicated in February that it would limit the treatment.

Several studies have indicated that sotrovimab doesn’t perform well against BA.2, including one published in Nature Medicine.

But GlaxoSmithKline and Vir Biotechnology, the makers of the drug, have said that testing suggested that the treatment retained neutralizing activity against BA.2.

The companies said on March 25 that they were aware of the FDA’s move and are preparing to send a data package to the agency and other regulatory authorities that show a higher dose of sotrovimab works against BA.2……read the rest.

The Truth Must be Told

Your contribution supports independent journalism

Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.

Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.

Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.

Please contribute here.

or

Make a monthly commitment to support The Geller Report – choose the option that suits you best.

• $25.00 here
• $50.00 here
• $75.00 here
• $100.00 here
• $250.00 here